Skip to content
RKWD
ROCKWOOD RESEARCH · A CORPORATE FILINGS WEBSITE|STRAIGHT FROM THE SOURCE · SEC EDGAR|SPONSOREDYour message on this tape — bid on the Rockwood Ad Exchange · Rockwood Ad Exchange|
Rockwood Research
…

TDOC

Teladoc Health, Inc.

Services-Offices & Clinics of Doctors of Medicine · SIC 8011CIK 1477449Held by 3 tracked managersEDGAR filings ↗10-K/10-Q ↗

SHARE:XLINKEDINEMAIL
Revenue FY2025
$2.53B
Net Income FY2025
$(0.20B)
EPS (Basic, as reported)
$-1.14
Net Margin FY2025
-7.9%
ROE FY2025
-14.5%
Total Equity
$1.39B
Shares Out
182M
Business description

Teladoc Health, Inc. — Services-Offices & Clinics of Doctors of Medicine. Figures are as reported in each year's original 10-K via SEC EDGAR XBRL company facts (FY2013–FY2025; structured XBRL data begins around 2008). Market-price metrics are not part of EDGAR data.

Annual (fiscal years, as reported)USD millions
i
default rows · click any row to chart itRevenue: 123 → 2,530 +39.9% CAGR
Fiscal yearFY2016FY2017FY2018FY2019FY2020⚑FY2021FY2022FY2023FY2024FY2025
Revenue1232334185531,0942,0332,4072,6022,5702,530
Cost of revenue(32)(62)(129)(184)(391)(650)(744)(760)(751)(772)
Gross profit91172289———————
Research & development(22)(34)(54)(65)(165)(312)(334)(349)(307)(278)
General & administrative(49)(80)(117)(158)(498)(438)(450)(465)(435)(432)
Total operating expenses—(309)(489)(634)(1,600)(2,298)(16,060)(2,851)(3,590)(2,793)
Operating income(63)(75)(71)(80)(506)(266)(13,653)(249)(1,021)(263)
Interest expense—————(81)(22)(22)(24)(20)
Interest & investment income—————113475737
Other income (expense), net———0(1)5(1)4(6)10
Pre-tax income(74)(107)(97)(109)(576)(385)(13,663)(220)(994)(236)
Income tax expense(1)00(11)(91)(44)(4)(1)(8)(35)
Net income(74)(107)(97)(99)(485)(429)(13,660)(220)(1,001)(200)
EPS — basic———($1.38)($5.36)($2.73)($84.60)($1.34)($5.87)($1.14)
EPS — diluted———($1.38)($5.36)($2.73)($84.60)($1.34)($5.87)($1.14)
Shares outstanding — basic (M)———7291157161165171176
Shares outstanding — diluted (M)———7291157161165171176

Showing the latest 10 of 13 fiscal years.

  • ⚑ Weighted-average shares changed ×1.73 between FY2020 and FY2021 — a large issuance or reduction. Per-share figures on either side are as reported and not adjusted.

Source: SEC EDGAR XBRL company facts — figures as reported in each period's original filing (structured data begins ~2008). EPS and other per-share figures are as reported and are not adjusted for later stock splits; a ⚑ marks a period where the reported share count changed by a large factor. Dollar figures in millions unless per-share. Line items a company never reports are omitted. Where a filer switched XBRL concepts, the successor concept is used and definitions can differ slightly (e.g. cash may include restricted cash; banks' revenue is net of interest expense; cost of revenue may exclude D&A; net income may be the amount available to common stockholders; debt issued/repaid may be net of issuance costs or include finance-lease obligations — each only where the original concept stopped being reported). Click a period header to open that period's source filing on EDGAR.